Next Article in Journal
Access to COVID-19 Vaccines: A New Global Approach
Next Article in Special Issue
Changing Ecotypes of Dengue Virus 2 Serotype in Nigeria and the Emergence of Cosmopolitan and Asian I Lineages, 1966–2019
Previous Article in Journal
Factors Influencing the Choice to Advise for or against COVID-19 Vaccination in the Physicians and Dentists of an Italian Region
Previous Article in Special Issue
Effective Functional Immunogenicity of a DNA Vaccine Combination Delivered via In Vivo Electroporation Targeting Malaria Infection and Transmission
 
 
Review
Peer-Review Record

An Overview of Rift Valley Fever Vaccine Development Strategies

Vaccines 2022, 10(11), 1794; https://doi.org/10.3390/vaccines10111794
by Paul Kato Kitandwe 1,*, Paul F. McKay 2, Pontiano Kaleebu 1 and Robin J. Shattock 2
Reviewer 1: Anonymous
Reviewer 2:
Reviewer 3: Anonymous
Vaccines 2022, 10(11), 1794; https://doi.org/10.3390/vaccines10111794
Submission received: 13 September 2022 / Revised: 13 October 2022 / Accepted: 21 October 2022 / Published: 25 October 2022

Round 1

Reviewer 1 Report

This is a well-written review on RVFV vaccines. The manuscript is well organized and appropriate references used. The authors did discuss the need for DIVA vaccines, which is an important topic in vaccine development. Well done!

Author Response

Dear Reviewer, in response to your comment, please find attached a revised manuscript with track changes. The English language has been proofread and the necessary corrections made. Thank you.

Author Response File: Author Response.docx

Reviewer 2 Report

Excellent manuscript. No comments.

Author Response

Dear Reviewer, I have made minor English proofreading checks to the manuscript in response to a comment I received from two of the reviewers who checked the box "English language and style are fine/minor spell check required". Please find attached the revised manuscript with track changes. Thank you

Author Response File: Author Response.docx

Reviewer 3 Report

In this manuscript, the authors explore the progress in Rift Valley Fever vaccine research and development. This is an exceptionally well-written, exhaustive review of an array of strategies in RVF vaccine development. Table 1 is very clear and concise. I recommend this manuscript for publication in Vaccines in present form.

 

Author Response

Dear Reviewer, in response to your comment, please find attached a revised manuscript with track changes. The English language has been proofread and the necessary corrections made. Thank you.

Author Response File: Author Response.docx

Back to TopTop